Mono Pharmacare Limited (NSE:MONOPHARMA)

Market Cap	158.13M -58.5%
Revenue (ttm)	1.66B -1.6%
Net Income	3.53M -88.6%
EPS	0.20 -88.6%
Shares Out	17.67M
PE Ratio	44.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,000
Open	8.25
Previous Close	8.95
Day's Range	8.25 - 8.95
52-Week Range	7.50 - 25.50
Beta	-0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Mono Pharmacare

Mono Pharmacare Limited engages in the distribution of pharmaceutical items in India. The company markets healthcare products, such as antibiotics, cough cold anti allergics, antifungal, nutraceutical, analgesic and antipyretic, antacid and antiemetic, cardiac diabetic, skincare, antiseptic, bronchodilators, probiotics, and antihistamines. It also offers products under the Cosmo Care brand; eye and ear drops, nasal spray, gynec, herbal, and skincare products. The company was founded in 1964 and is based in Ahmedabad, India.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1964
• Employees: 115
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MONOPHARMA

Financial Performance

In fiscal year 2026, Mono Pharmacare's revenue was 1.66 billion, a decrease of -1.62% compared to the previous year's 1.68 billion. Earnings were 3.53 million, a decrease of -88.58%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error